169 related articles for article (PubMed ID: 16715213)
1. Metabolic effects of telmisartan in spontaneously hypertensive rats.
Li YQ; Ji H; Zhang YH; Ding DY; Ye XL
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):264-70. PubMed ID: 16715213
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
3. Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation.
Müller-Fielitz H; Landolt J; Heidbreder M; Werth S; Vogt FM; Jöhren O; Raasch W
Endocrinology; 2012 Mar; 153(3):1103-15. PubMed ID: 22253423
[TBL] [Abstract][Full Text] [Related]
4. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension.
Pravenec M; Landa V; Zídek V; Musilová A; Kazdová L; Qi N; Wang J; St Lezin E; Kurtz TW
Physiol Res; 2003; 52(6):681-8. PubMed ID: 14640889
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
Liu W; Yamashita T; Kurata T; Kono S; Hishikawa N; Deguchi K; Zhai Y; Abe K
Neurol Res; 2015 Jun; 37(6):491-501. PubMed ID: 25591419
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone.
Qi N; Kazdova L; Zidek V; Landa V; Kren V; Pershadsingh HA; Lezin ES; Abumrad NA; Pravenec M; Kurtz TW
J Biol Chem; 2002 Dec; 277(50):48501-7. PubMed ID: 12384507
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.
Aitman TJ; Glazier AM; Wallace CA; Cooper LD; Norsworthy PJ; Wahid FN; Al-Majali KM; Trembling PM; Mann CJ; Shoulders CC; Graf D; St Lezin E; Kurtz TW; Kren V; Pravenec M; Ibrahimi A; Abumrad NA; Stanton LW; Scott J
Nat Genet; 1999 Jan; 21(1):76-83. PubMed ID: 9916795
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
Seda O; Kazdova L; Krenova D; Kren V
Physiol Genomics; 2003 Jan; 12(2):73-8. PubMed ID: 12429866
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
[TBL] [Abstract][Full Text] [Related]
12. Does Cd36 gene play a key role in disturbed glucose and fatty acid metabolism in Prague hypertensive hypertriglyceridemic rats?
Kadlecová M; Cejka J; Zicha J; Kunes J
Physiol Res; 2004; 53(3):265-71. PubMed ID: 15209533
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
[TBL] [Abstract][Full Text] [Related]
14. High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.
Bähr IN; Tretter P; Krüger J; Stark RG; Schimkus J; Unger T; Kappert K; Scholze J; Parhofer KG; Kintscher U
Hypertension; 2011 Oct; 58(4):725-32. PubMed ID: 21876071
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
Younis F; Oron Y; Limor R; Stern N; Rosenthal T
Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
[TBL] [Abstract][Full Text] [Related]
16. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Kono S; Kurata T; Sato K; Omote Y; Hishikawa N; Yamashita T; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):537-47. PubMed ID: 25534368
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
[TBL] [Abstract][Full Text] [Related]
18. Mitigation of Insulin Resistance by Mangiferin in a Rat Model of Fructose-Induced Metabolic Syndrome Is Associated with Modulation of CD36 Redistribution in the Skeletal Muscle.
Zhou L; Pan Y; Chonan R; Batey R; Rong X; Yamahara J; Wang J; Li Y
J Pharmacol Exp Ther; 2016 Jan; 356(1):74-84. PubMed ID: 26498906
[TBL] [Abstract][Full Text] [Related]
19. Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion.
Deguchi K; Kurata T; Fukui Y; Liu W; Yun Z; Omote Y; Sato K; Kono S; Hishikawa N; Yamashita T; Abe K
J Stroke Cerebrovasc Dis; 2014; 23(10):2646-2653. PubMed ID: 25307428
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
